Kazue Ishikawa

542 total citations
19 papers, 453 citations indexed

About

Kazue Ishikawa is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kazue Ishikawa has authored 19 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kazue Ishikawa's work include Electron Spin Resonance Studies (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). Kazue Ishikawa is often cited by papers focused on Electron Spin Resonance Studies (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). Kazue Ishikawa collaborates with scholars based in Japan and United States. Kazue Ishikawa's co-authors include Toshio Matsumoto, Sumiko Yoshida, Masashi Akaike, Shusuke Yagi, Ken‐ichi Aihara, Takashi Iwase, Yasumasa Ikeda, Takayuki Ise, Masataka Sata and Hiroyuki Azuma and has published in prestigious journals such as Circulation, Circulation Research and Endocrine Reviews.

In The Last Decade

Kazue Ishikawa

19 papers receiving 446 citations

Peers

Countries citing papers authored by Kazue Ishikawa

Since Specialization

Citations

This map shows the geographic impact of Kazue Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazue Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazue Ishikawa more than expected).

Fields of papers citing papers by Kazue Ishikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazue Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazue Ishikawa. The network helps show where Kazue Ishikawa may publish in the future.

Co-authorship network of co-authors of Kazue Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kazue Ishikawa. A scholar is included among the top collaborators of Kazue Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazue Ishikawa. Kazue Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Effectiveness of Advance Care Planning for People with Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis 2022 ·Journal of Japan Academy of Nursing Science ·(unknown), Kazue Ishikawa, (unknown), Tomoko Kamei	1
2	Effectiveness of negative pressure wound therapy for the wound of ileostomy closure: a multicenter, phase II randomized controlled trial 2021 ·BMC Surgery ·(unknown), (unknown), Yasuo Nagashima, Yōko Saitō, (unknown), (unknown), (unknown), (unknown), Kazue Ishikawa, Hiroyoshi Matsuoka, Tadahiko Masaki, Eiji Sunami, Norihiko Ohura, Koji Teruya, Ken Eto, Keijiro Nozawa, Kazuhiro Sakamoto, Kimihiko Funahashi	6
3	Endothelial Nitric Oxide Synthase-Independent Pleiotropic Effects of Pitavastatin Against Atherogenesis and Limb Ischemia in Mice 2017 ·Journal of Atherosclerosis and Thrombosis ·Takeshi Mitsuhashi, (unknown), Kazue Ishikawa, Sumiko Yoshida, Yasumasa Ikeda, Shusuke Yagi, Toshio Matsumoto, Masashi Akaike, Ken‐ichi Aihara	6
4	The Role of Heparin Cofactor Ⅱ in the Regulation of Insulin Sensitivity and Maintenance of Glucose Homeostasis in Humans and Mice 2017 ·Journal of Atherosclerosis and Thrombosis ·Kiyoe Kurahashi, (unknown), Sumiko Yoshida, Yasumasa Ikeda, (unknown), (unknown), Kazue Ishikawa, Takeshi Kondo, Tomoyuki Yuasa, Itsuro Endo, Masato Miyake, Seiichi Oyadomari, Toshio Matsumoto, Masahiro Abe, Hiroshi Sakaue, Ken‐ichi Aihara	9
5	Clinical Nursing Competencies of Caring for Hansen's Disease Survivors During the Final Career Stage of Nurses' Development in Japan 2015 ·Atsuko Nakayama, Kazue Ishikawa, (unknown)	1
6	Androgen Receptor Promotes Sex-Independent Angiogenesis in Response to Ischemia and Is Required for Activation of Vascular Endothelial Growth Factor Receptor Signaling 2013 ·Circulation ·Sumiko Yoshida, Ken‐ichi Aihara, Yasumasa Ikeda, (unknown), (unknown), Kazue Ishikawa, Takayuki Ise, Shusuke Yagi, Takashi Iwase, Yasuhiro Mouri, Matomo Sakari, Takahiro Μatsumoto, Ken‐ichi Takeyama, Masashi Akaike, Mitsuru Matsumoto, Masataka Sata, Kenneth Walsh, Shigeaki Kato, Toshio Matsumoto	50
7	New Evaluation of Both α- and β-Amylase Activity in Plants and its Application to Food Materials 2011 ·Journal of home economics ·(unknown), Kazue Ishikawa, (unknown), Takashi Nanmori	1
8	Activation of Peroxisome Proliferator-Activated Receptor α in Megakaryocytes Reduces Platelet-Derived Growth Factor-BB in Platelets 2011 ·Journal of Atherosclerosis and Thrombosis ·Shunji Hashizume, Masashi Akaike, Hiroyuki Azuma, Kazue Ishikawa, Sumiko Yoshida, (unknown), Shusuke Yagi, Yasumasa Ikeda, Takashi Iwase, Ken‐ichi Aihara, Masahiro Abe, Masataka Sata, Toshio Matsumoto	10
9	Effect of Low-Dose (1 mg/day) Pitavastatin on Left Ventricular Diastolic Function and Albuminuria in Patients With Hyperlipidemia 2011 ·The American Journal of Cardiology ·Shusuke Yagi, Masashi Akaike, Ken‐ichi Aihara, Takashi Iwase, Kazue Ishikawa, Sumiko Yoshida, (unknown), Kenya Kusunose, Toshiyuki Niki, Koji Yamaguchi, Kunihiko Koshiba, Yoshio Taketani, Noriko Tomita, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Toshio Matsumoto, Masataka Sata	12
10	High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension 2010 ·Hypertension Research ·Shusuke Yagi, Masashi Akaike, Ken‐ichi Aihara, Takashi Iwase, Sumiko Yoshida, (unknown), Yasumasa Ikeda, Kazue Ishikawa, Toshio Matsumoto, Masataka Sata	42
11	Ezetimibe Ameliorates Metabolic Disorders and Microalbuminuria in Patients with Hypercholesterolemia 2010 ·Journal of Atherosclerosis and Thrombosis ·Shusuke Yagi, Masashi Akaike, Ken‐ichi Aihara, Takashi Iwase, Kazue Ishikawa, Sumiko Yoshida, (unknown), Kenya Kusunose, Toshiyuki Niki, Koji Yamaguchi, Kunihiko Koshiba, Yoichiro Hirata, Munkhbaatar Dagvasumberel, Yoshio Taketani, Noriko Tomita, Hirotsugu Yamada, Takeshi Soeki, Tetsuzo Wakatsuki, Toshio Matsumoto, Masataka Sata	41
12	Endothelial Nitric Oxide Synthase–Independent Protective Action of Statin Against Angiotensin II–Induced Atrial Remodeling via Reduced Oxidant Injury 2010 ·Hypertension ·Shusuke Yagi, Masashi Akaike, Ken‐ichi Aihara, Kazue Ishikawa, Takashi Iwase, Yasumasa Ikeda, Takeshi Soeki, Sumiko Yoshida, (unknown), Toshio Matsumoto, Masataka Sata	51
13	Androgen Receptor Counteracts Doxorubicin-Induced Cardiotoxicity in Male Mice 2010 ·Molecular Endocrinology ·Yasumasa Ikeda, Ken‐ichi Aihara, Masashi Akaike, Takashi Sato, Kazue Ishikawa, Takayuki Ise, Shusuke Yagi, Takashi Iwase, Yuka Ueda, Sumiko Yoshida, Hiroyuki Azuma, Kenneth Walsh, Toshiaki Tamaki, Shigeaki Kato, Toshio Matsumoto	55
14	Androgen Receptor Counteracts Doxorubicin-Induced Cardiotoxicity in Male Mice 2010 ·Endocrine Reviews ·Yasumasa Ikeda, (unknown), Masashi Akaike, Takashi Sato, Kazue Ishikawa, Takayuki Ise, Shusuke Yagi, Takashi Iwase, Yuka Ueda, Sumiko Yoshida, Hiroyuki Azuma, Kenneth Walsh, Toshiaki Tamaki, Shigeaki Kato, Toshio Matsumoto	1
15	Androgen Receptor Counteracts Doxorubicin-Induced Cardiotoxicity in Male Mice 2010 ·The Journal of Clinical Endocrinology & Metabolism ·Yasumasa Ikeda, (unknown), Masashi Akaike, Takashi Sato, Kazue Ishikawa, Takayuki Ise, Shusuke Yagi, Takashi Iwase, Yuka Ueda, Sumiko Yoshida, Hiroyuki Azuma, Kenneth Walsh, Toshiaki Tamaki, Shigeaki Kato, Toshio Matsumoto	1
16	Heparin Cofactor II Protects Against Angiotensin II-Induced Cardiac Remodeling Via Attenuation of Oxidative Stress in Mice 2010 ·Hypertension ·(unknown), Ken‐ichi Aihara, Takayuki Ise, Sumiko Yoshida, Yasumasa Ikeda, (unknown), Shusuke Yagi, Takashi Iwase, Kazue Ishikawa, Yoichiro Hirata, Masashi Akaike, Masataka Sata, Shigeaki Kato, Toshio Matsumoto	23
17	Heparin Cofactor II is an Independent Protective Factor against Peripheral Arterial Disease in Elderly Subjects with Cardiovascular Risk Factors 2009 ·Journal of Atherosclerosis and Thrombosis ·Ken‐ichi Aihara, Hiroyuki Azuma, Masashi Akaike, Hirotsugu Kurobe, (unknown), Yasumasa Ikeda, (unknown), Sumiko Yoshida, Shusuke Yagi, Takashi Iwase, Kazue Ishikawa, Masataka Sata, Tetsuya Kitagawa, Toshio Matsumoto	14
18	Androgen-Androgen Receptor System Protects against Angiotensin II-Induced Vascular Remodeling 2009 ·Endocrinology ·Yasumasa Ikeda, Ken‐ichi Aihara, Sumiko Yoshida, Takashi Sato, Shusuke Yagi, Takashi Iwase, (unknown), Takayuki Ise, Kazue Ishikawa, Hiroyuki Azuma, Masashi Akaike, Shigeaki Kato, Toshio Matsumoto	56
19	Pitavastatin, an HMG-CoA Reductase Inhibitor, Exerts eNOS-Independent Protective Actions Against Angiotensin II–Induced Cardiovascular Remodeling and Renal Insufficiency 2007 ·Circulation Research ·Shusuke Yagi, Ken‐ichi Aihara, Yasumasa Ikeda, (unknown), Sumiko Yoshida, Takayuki Ise, Takashi Iwase, Kazue Ishikawa, Hiroyuki Azuma, Masashi Akaike, Toshio Matsumoto	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact